BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Machuca-Parra AI, Bigger-Allen AA, Sanchez AV, Boutabla A, Cardona-Vélez J, Amarnani D, Saint-Geniez M, Siebel CW, Kim LA, D'Amore PA, Arboleda-Velasquez JF. Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL. J Exp Med 2017;214:2271-82. [PMID: 28698285 DOI: 10.1084/jem.20161715] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 He H, Yang W, Su N, Zhang C, Dai J, Han F, Singhal M, Bai W, Zhu X, Zhu J, Liu Z, Xia W, Liu X, Zhang C, Jiang K, Huang W, Chen D, Wang Z, He X, Kirchhoff F, Li Z, Liu C, Huan J, Wang X, Wei W, Wang J, Augustin HG, Hu J. Activating NO–sGC crosstalk in the mouse vascular niche promotes vascular integrity and mitigates acute lung injury. Journal of Experimental Medicine 2023;220. [DOI: 10.1084/jem.20211422] [Reference Citation Analysis]
2 Li J, Luo T, Wang X, Wang M, Zheng T, Dang X, Deng A, Zhang Y, Ding S, Jing P, Zhu L. A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.943117] [Reference Citation Analysis]
3 Hankeova S, Van Hul N, Laznovsky J, Verboven E, Mangold K, Hensens N, Adori C, Verhoef E, Zikmund T, Dawit F, Kavkova M, Salplachta J, Sjöqvist M, Johansson BR, Hassan MG, Fredriksson L, Baumgärtel K, Bryja V, Lendahl U, Jheon A, Alten F, Fahnehjelm KT, Fischler B, Kaiser J, Andersson ER. Sex differences and risk factors for bleeding in Alagille syndrome. EMBO Mol Med 2022. [DOI: 10.15252/emmm.202215809] [Reference Citation Analysis]
4 Hopkins CE, Brock T, Caulfield TR, Bainbridge M. Phenotypic screening models for rapid diagnosis of genetic variants and discovery of personalized therapeutics. Molecular Aspects of Medicine 2022. [DOI: 10.1016/j.mam.2022.101153] [Reference Citation Analysis]
5 Oliveira DV, Coupland KG, Jin S, Del Gaudio F, Wang S, Fox R, Rutten JW, Sandin J, Lundkvist J, Lesnik Oberstein SAJ, Lendahl U, Karlström H. NOTCH3 active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model.. [DOI: 10.1101/2022.07.11.499563] [Reference Citation Analysis]
6 Enyong EN, Gurley JM, De Ieso ML, Stamer WD, Elliott MH. Caveolar and non-Caveolar Caveolin-1 in ocular homeostasis and disease. Prog Retin Eye Res 2022;:101094. [PMID: 35729002 DOI: 10.1016/j.preteyeres.2022.101094] [Reference Citation Analysis]
7 Del Gaudio F, Liu D, Lendahl U. Notch signalling in healthy and diseased vasculature. Open Biol 2022;12:220004. [PMID: 35472289 DOI: 10.1098/rsob.220004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Tiemeijer LA, Sanlidag S, Bouten CVC, Sahlgren CM. Engineering tissue morphogenesis: taking it up a Notch. Trends Biotechnol 2022:S0167-7799(22)00007-5. [PMID: 35181146 DOI: 10.1016/j.tibtech.2022.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yan X, Shang J, Wang R, Wang F, Zhang J. Mechanisms regulating cerebral hypoperfusion in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Biomed Res 2022;36:353. [DOI: 10.7555/jbr.36.20220208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Matsuura N, Tanaka K, Yamasaki M, Yamashita K, Saito T, Makino T, Yamamoto K, Takahashi T, Kurokawa Y, Nakajima K, Eguchi H, Nakagawa H, Doki Y. NOTCH3 limits the epithelial-mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer. Cancer Med 2021;10:3986-96. [PMID: 34042293 DOI: 10.1002/cam4.3933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Schoemaker D, Arboleda-Velasquez JF. Notch3 Signaling and Aggregation as Targets for the Treatment of CADASIL and Other NOTCH3-Associated Small-Vessel Diseases. Am J Pathol 2021;191:1856-70. [PMID: 33895122 DOI: 10.1016/j.ajpath.2021.03.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
12 Arnardottir S, Del Gaudio F, Klironomos S, Braune EB, Lombraña AA, Oliveira DV, Jin S, Karlström H, Lendahl U, Sjöstrand C. Novel Cysteine-Sparing Hypomorphic NOTCH3 A1604T Mutation Observed in a Family With Migraine and White Matter Lesions. Neurol Genet 2021;7:e584. [PMID: 33898742 DOI: 10.1212/NXG.0000000000000584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hankeova S, Van Hul N, Laznovsky J, Mangold K, Hensens N, Verhoef E, Zikmund T, Dawit F, Kavkova M, Salplachta J, Sjöqvist M, Johansson BR, Hassan M, Fredriksson L, Bryja V, Lendahl U, Jheon A, Alten F, Fahnehjelm KT, Fischler B, Kaiser J, Andersson ER. Sex differences and risk factors for bleeding in Alagille syndrome.. [DOI: 10.1101/2021.04.13.439679] [Reference Citation Analysis]
14 Manini A, Pantoni L. CADASIL from Bench to Bedside: Disease Models and Novel Therapeutic Approaches. Mol Neurobiol 2021;58:2558-73. [PMID: 33464533 DOI: 10.1007/s12035-021-02282-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Nadeem T, Bogue W, Bigit B, Cuervo H. Deficiency of Notch signaling in pericytes results in arteriovenous malformations. JCI Insight 2020;5:125940. [PMID: 33148887 DOI: 10.1172/jci.insight.125940] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
16 Yuan C, Ni L, Zhang C, Wu X. The Role of Notch3 Signaling in Kidney Disease. Oxid Med Cell Longev 2020;2020:1809408. [PMID: 33149805 DOI: 10.1155/2020/1809408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Maroney Z, Dale R. Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL): A Rare Diagnosis in a Patient With Schizophrenia. Psychosomatics 2020;61:395-9. [PMID: 31924337 DOI: 10.1016/j.psym.2019.11.003] [Reference Citation Analysis]
18 Rangasamy S, Monickaraj F, Legendre C, Cabrera AP, Llaci L, Bilagody C, McGuire P, Das A. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy. Exp Eye Res 2020;195:108043. [PMID: 32376470 DOI: 10.1016/j.exer.2020.108043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
19 Hosseini-Alghaderi S, Baron M. Notch3 in Development, Health and Disease. Biomolecules 2020;10:E485. [PMID: 32210034 DOI: 10.3390/biom10030485] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
20 Qian S, Li R, Zhang C, Zhang R, Guo D, Bu X, Wang A, Peng H, Chen J, Zhang Y, He J, Xu T, Zhong C. Plasma Endostatin Levels at Acute Phase of Ischemic Stroke Are Associated with Post-Stroke Cognitive Impairment. Neurotox Res 2020;37:956-64. [PMID: 32034697 DOI: 10.1007/s12640-020-00173-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Gallardo A, Latapiat V, Rivera A, Fonseca B, Roldan A, Sandoval P, Sánchez C, Matamala JM. NOTCH3 Gene Mutation in a Chilean Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Family. Journal of Stroke and Cerebrovascular Diseases 2020;29:104530. [DOI: 10.1016/j.jstrokecerebrovasdis.2019.104530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Henninger N, Mayasi Y. Nucleic Acid Therapies for Ischemic Stroke. Neurotherapeutics 2019;16:299-313. [PMID: 30635869 DOI: 10.1007/s13311-019-00710-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
23 Haffner C. Proteostasis in Cerebral Small Vessel Disease. Front Neurosci 2019;13:1142. [PMID: 31798396 DOI: 10.3389/fnins.2019.01142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Mustapha M, Nassir CMNCM, Aminuddin N, Safri AA, Ghazali MM. Cerebral Small Vessel Disease (CSVD) - Lessons From the Animal Models. Front Physiol 2019;10:1317. [PMID: 31708793 DOI: 10.3389/fphys.2019.01317] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
25 Coupland K, Lendahl U, Karlström H. Role of NOTCH3 Mutations in the Cerebral Small Vessel Disease Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy. Stroke 2018;49:2793-800. [PMID: 30355220 DOI: 10.1161/STROKEAHA.118.021560] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
26 Ho DM, Artavanis-Tsakonas S, Louvi A. The Notch pathway in CNS homeostasis and neurodegeneration. Wiley Interdiscip Rev Dev Biol 2020;9:e358. [PMID: 31502763 DOI: 10.1002/wdev.358] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
27 Wallin A, Román GC, Esiri M, Kettunen P, Svensson J, Paraskevas GP, Kapaki E. Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease. J Alzheimers Dis 2018;62:1417-41. [PMID: 29562536 DOI: 10.3233/JAD-170803] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 23.0] [Reference Citation Analysis]
28 Machowska- Sempruch K, Bajer- Czajkowska A, Makarewicz K, Zaryczańska K, Koryzma A, Nowacki P. A Novel NOTCH3 Gene Mutation in a Polish CADASIL Family. Journal of Stroke and Cerebrovascular Diseases 2019;28:574-6. [DOI: 10.1016/j.jstrokecerebrovasdis.2018.10.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Miloudi K, Oubaha M, Ménard C, Dejda A, Guber V, Cagnone G, Wilson AM, Tétreault N, Mawambo G, Binet F, Chidiac R, Delisle C, Buscarlet M, Cerani A, Crespo-Garcia S, Bentley K, Rezende F, Joyal JS, Mallette FA, Gratton JP, Larrivée B, Sapieha P. NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy. Proc Natl Acad Sci U S A 2019;116:4538-47. [PMID: 30787185 DOI: 10.1073/pnas.1814711116] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
30 Rippe C, Albinsson S, Guron G, Nilsson H, Swärd K. Targeting transcriptional control of soluble guanylyl cyclase via NOTCH for prevention of cardiovascular disease. Acta Physiol (Oxf) 2019;225:e13094. [PMID: 29754438 DOI: 10.1111/apha.13094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Zhang M, Xu B, Siehr A, Shen W. Efficient release of immunocaptured cells using coiled-coils in a microfluidic device. RSC Adv 2019;9:29182-9. [DOI: 10.1039/c9ra03871j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Liu H, Zhang W, Lilly B. Evaluation of Notch3 Deficiency in Diabetes-Induced Pericyte Loss in the Retina. J Vasc Res 2018;55:308-18. [PMID: 30347392 DOI: 10.1159/000493151] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
33 Karschnia P, Nishimura S, Louvi A. Cerebrovascular disorders associated with genetic lesions. Cell Mol Life Sci 2019;76:283-300. [PMID: 30327838 DOI: 10.1007/s00018-018-2934-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
34 Ghezali L, Capone C, Baron-Menguy C, Ratelade J, Christensen S, Østergaard Pedersen L, Domenga-Denier V, Pedersen JT, Joutel A. Notch3ECD immunotherapy improves cerebrovascular responses in CADASIL mice. Ann Neurol 2018;84:246-59. [PMID: 30014602 DOI: 10.1002/ana.25284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
35 Zellner A, Scharrer E, Arzberger T, Oka C, Domenga-Denier V, Joutel A, Lichtenthaler SF, Müller SA, Dichgans M, Haffner C. CADASIL brain vessels show a HTRA1 loss-of-function profile. Acta Neuropathol 2018;136:111-25. [PMID: 29725820 DOI: 10.1007/s00401-018-1853-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
36 Bernhardt J, Zorowitz RD, Becker KJ, Keller E, Saposnik G, Strbian D, Dichgans M, Woo D, Reeves M, Thrift A, Kidwell CS, Olivot JM, Goyal M, Pierot L, Bennett DA, Howard G, Ford GA, Goldstein LB, Planas AM, Yenari MA, Greenberg SM, Pantoni L, Amin-hanjani S, Tymianski M. Advances in Stroke 2017. Stroke 2018;49. [DOI: 10.1161/strokeaha.118.021380] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
37 Vinters HV, Zarow C, Borys E, Whitman JD, Tung S, Ellis WG, Zheng L, Chui HC. Review: Vascular dementia: clinicopathologic and genetic considerations. Neuropathol Appl Neurobiol 2018;44:247-66. [DOI: 10.1111/nan.12472] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 12.3] [Reference Citation Analysis]